In this study, aspirin was shown to affect TCF/LEF, NF-κB, and NRF2 promoter transcriptional activities and downstream factors (c-Myc, IL-6, and HO-1) in human colon cancer cells. This evidence concerns the gene MYC and colonic neoplasm.